SOURCE: SimySkin Inc.

November 14, 2013 15:05 ET

Targeted Skin Solutions for Every Phase of Your Life

PARIS, FRANCE--(Marketwired - Nov 14, 2013) - SimySkin Inc. is pleased to announce its entry into the ever growing anti aging cosmeceutical arena. SimySkin Inc. is a Florida based anti aging focused company which embraces the paradigm of systems biology with its first 100% "Made in France" anti aging eye serum.

SimySkin Inc. has launched its website (www.simyskin.com) this month and intends to launch its first product line, developed, manufactured and packaged in the south of France, to select distributors starting in December 2013.

The first SimySkin™ product line is an anti aging eye serum which targets 3 distinct age groups (18-25/ 25-45 and 45 +) with unique outcomes for each age group: "targeted skin solutions for every phase of your life."

"The SimySkin™ philosophy embraces the concept of Systems Biology wherein it is viewed that the skin, as a living organ, emerges from the interactions of the individual elements that make up its constitutional cells," declared Dr Uri Sagman, a Toronto, Canada Oncologist and one of the founders of the company, who added, "The skin is necessarily a network of interconnected elements whose behavior is modulated by intrinsic elements and external triggers...the SimySkin™ anti aging eye serum was designed to target critical elements in the skin network that systematically improves the structure, function and ultimately, the appearance of the skin."

SimySkin Inc. intends to develop further lines of anti aging products which conform to international standards and regulations and are geared towards cost conscious consumers who appreciate high standards of scientific excellence, safe and efficient products, and environmentally friendly and elegant packaging.

While Dr Sagman brings a high level of academia and scientific research, Georges Benarroch, based in Paris, France, one of the founders of SimySkin Inc. and its CEO, brings decades of investment banking experience as President of Comindus Finance. "Together with Dr Sagman, we have spent the last 12 years developing innovative anticancer therapeutics at Kyto IP., our biotechnology company. Our expertise in the Vitamin B12 pathway and in biological targeting technology combined with our understanding of the cosmetics business model, provided us with the impetus to develop differentiated products in the anti aging field," concluded Georges Benarroch.

Contact Information